Improving the cost and speed of clinical trials has been a long time coming. While plenty of hurdles remain, Radicle Science is doing it – all the while maintaining scientific rigor and bettering the generalizability of the findings.
A nonprofit accreditation body, Empowered by Evidence (EBE), gave an impassioned presentation to the audience of Vitafoods 2023, calling for companies to promote better standards in industry science.
Daily oral Colartix hydrolyzed cartilage matrix (HCM) supplementation may improve joint discomfort in a wide variety of people, according to real-world data collected using a novel mobile app.
A clinical trial has found that Kerry Group’s probiotic strain Sporevia (Bacillus subtilis MB40) can eliminate Staphylococcus aureus in the human body by more than 95%.
This round-up will feature scientific findings from big brand names, including Swisse and its study of krill oil supplementation on knee osteoarthritis, Amway’s personalised nutrition, and India’s national research agency’s plans for studying cannabidiol...
With consumers increasingly demanding scientifically-validated nutra products and ingredients, one of the key scientists in Australia’s national research agency has revealed the three factors that are crucial for a high-quality trial.
The supplementation of vitamin C has been found to improve attention, work motivation and reaction time in young adults, according to a study conducted in South Korea.
A FANCL-funded RCT study has discovered that the ingestion of tea flower extract, mulberry leaf extract, and chitosan could reduce postprandial blood glucose and triglyceride levels in healthy subjects.
Clinical trials involving diet are severely under-funded and more difficult to complete than drugs studies, say researchers who warn that nutrition studies are prone to bias, are often too small and of too short duration and regularly change outcome...
A growing number of clinical studies focusing on probiotics is seen in Asia, with China and Iran seeing exponential increase in recent years, according to an International Probiotics Association-backed review.
DSM has entered a regional agreement with SLS Nutraceuticals, a subsidiary of biotechnology company Senescence Life Sciences, in a bid to improve brain health across all life stages in the Asia-Pacific region.
Daily supplementation with vitamin D3 at three times the standard dose provides no additional bone strength benefits in healthy infants, a clinical trial has found.
A supplement with an ingredient combo including L-theanine, beta-alanine, and theacrine may help users increase brain alertness, researchers concluded after a placebo-controlled clinical trial.
Qatar University researchers are conducting an RCT to assess the effectiveness of protein supplementation in lowering the risk of protein malnutrition and muscle wasting in post-bariatric surgery patients.
Saffron fared better than a placebo in improving depression symptoms among mothers with mild post-partum depression, say researchers at the Mashhad University of Medical Sciences in Iran.
A new study on Natreon’s AyuFlex botanical ingredient shows decreased joint pain and increased mobility among a study population of overweight adults. It’s part of the company’s strategy to support entry into new markets with hard data on its ingredients.
What can pharmaceutical and nutrition industries learn from each other, and is the historical divide between the two slowly starting to be bridged? In this special edition article we look at how the two worlds of pharma and nutrition are colliding.
In a systematic review, researchers in Brazil concluded that with the science available, “it would not be appropriate to recommend, at the moment”, the clinical use of prebiotics, or its combination with probiotics, to tackle obesity-related health risks.
Daily supplements containing Rhodiola rosea extract may improve the symptoms of burnout, suggests data from the first trial to examine the effects of the botanical extract on this modern day condition.
Top-level speakers from a raft of major probiotics manufacturers and suppliers will join international academics to present at our first Probiota Asia summit in Singapore in October.
Restrictions on word counts in scientific journals on the reporting of trials on the efficacy of supplements can hinder the quality of the reporting of the study, according to the author of a study which judged the quality of reporting to be “poor”.
The need for robust research to validate health claims for a food ingredient has never been in doubt. But with regulations becoming ever more stringent the role of Contract Research Organisations (CROs) appears to be changing.
A trial on a novel infant formula appears to shows for the first time that a specific combination of ingredients can have a preventive effect on colic.
Development of products with urolithin A, a metabolite from pomegranate compounds, took a big step forward as scientists reported results from a Phase 1 trial supporting the safety, bioavailability, and biological activity of the compound.
Having quickly established its credentials in the sports nutrition space, positive results in recent clinical trials are creating new opportunities for Nutrition 21’s Nitrosigine in the cognitive health sector.
A recent review paper that called into question the potential benefits of curcumin has been misinterpreted to create inaccurate headlines, experts tell NutraIngredients-USA.
Researchers believe they have shown for the first time that probiotics can improve cognitive function in humans, following a clinical trial with elderly Alzheimer’s patients aged 60-95.
Clinical trials investigating the effects of prebiotics and probiotics on the microbiome have to move from an association to causation if the market is to evolve in the long-term.
Australian company Medlab Clinical Limited is preparing to start Australia’s first clinical trial using cannabis for oncology patients suffering intractable pain.
Irish biotech firm Nuritas has secured a €3m EU grant to continue research on an unnamed peptide it says is a major breakthrough in diabetes prevention.
A paper claiming the marketing of probiotics to treat mastitis is problematic has caused a controversy, but probiotics researchers and manufacturers say the science is sound.
Development of an in vitro model that mimics the gastrointestinal tract is one of the ways in which Biofortis and Triskelion hope to help further research into the relationship between the gut microbiome and immune health, under a new partnership.
Extracts from Terminalia chebula, a plant commonly used in ayurvedic medicine, may improve joint health in people with joint discomfort, says a new study.
Caffeine was observed to not improve repeated-sprint performance, while sodium phosphate was noted to only marginally improve repeated-sprint performance.
Soy supplements may reduce the risk of cardiovascular risk for people able to produce equol, a microbial-derived metabolite of the isoflavone daidzein, but equol supplements themselves may not have the same effects, says a new study.
A collaboration between Chr. Hansen and Caelus Health will focus on the development of Eubacterium hallii as a next generation probiotic for prevention and treatment of metabolic disease.
There is no evidence that the probiotic strain Bifidobacterium breve can reduce the risk of necrotising enterocolitis (NEC), late-onset sepsis and death in preterm infants, a study of 1315 infants has found.
Since taking the European Food Safety Authority (EFSA) throne last summer, Dr Bernhard Url has become something of a pin-up boy for the so-called new ‘open EFSA’. But how far exactly is this new executive director willing to take his vision of transparency?
Long term intake of a high-dose resveratrol supplement or drug may help people with mild to moderate Alzheimer's disease to stabilise a biomarker that declines when the disease progresses, say researchers.
Supplementation with epicatechin may beneficially affect insulin levels and insulin resistance, but another flavonoid quercetin had no effect, says a new study from The Netherlands.
Supplements of vitamin E may reduce the risk of myocardial infarction, says a new meta-analysis of 16 randomized clinical trials, but the effects seem to be canceled out when given other antioxidants.
